Indexed metadata
Lenalidomide in combination with intravenous rituximab (REVRI) in relapsed/refractory primary CNS lymphoma or primary intraocular lymphoma: a multicenter prospective ‘proof of concept’ phase II study of the French Oculo-Cerebral lymphoma (LOC) Network and the Lymphoma Study Association (LYSA)
H. Ghesquieres, M. Chevrier, M. Laadhari, O. Chinot, S. Choquet, C. Moluçon-Chabrot, P. Beauchesne, R. Gressin, F. Morschhauser, A. Schmitt, E. Gyan, K. Hoang-Xuan, E. Nicolas-Virelizier, N. Cassoux, V. Touitou, M. Le Garff-Tavernier, A. Savignoni, I. Turbiez, V. Soumelis, C. Houillier, C. Soussain
Evidence graph
No public relationships recorded yet.
Integrity note: This page is a factual metadata record created by deterministic ingestion. It is not a claim that the work moves a mathematical frontier or has been independently verified.